Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Net Loss Per Share [Abstract]

Schedule of Anti-dilutive Shares

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three months ended March 31, 2026 and 2025 are as follows:

	Three months ended March 31,
	2026		2025
	(Shares)		(Shares)
Convertible debt		669,844,166		1,978,891,288
Stock options		1,780,001		2,113,335
Warrants to purchase shares of Common Stock		397,325,496		993,777,942
		1,068,949,663		2,974,782,565